Intuitive Surgical Stock Plummets to New 52-Week Low of $396.84

Intuitive Surgical, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has recently reached a new 52-week low of USD 396.84 on June 2, 2026. This decline marks a significant shift in the stock's performance, as it has experienced a 1-year performance decrease of 3.84%, contrasting sharply with the S&P 500's impressive gain of 28.2% during the same period. The company's market capitalization stands at USD 171,691 million, categorizing it as a large-cap entity. Intuitive Surgical's price-to-earnings (P/E) ratio is currently at 60.00, indicating a premium valuation compared to many of its peers. Additionally, the company has a return on equity of 16.17%, reflecting its ability to generate profit from shareholders' equity. However, it is noteworthy that Intuitive Surgical does not offer a dividend yield, and its debt-to-equity ratio is reported at -0.33, suggesting a unique financial structure. As the stock navigates this new low, it remains to be seen how these financial metrics will influence its market position moving forward.